ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,551Medicare Part D Prescriptions Filled, Including Refills

Rank: 117 out of 3734

$911K Total Retail Price of All Prescriptions

Rank: 141 out of 3734

454 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

28% of this provider’s 454 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OXYCODONE-ACETAMINOPHEN 705 98 S2 1 51
HYDROCODONE-ACETAMINOPHEN 597 213 S3 2 12
OMEPRAZOLE 544 203 3 4
LISINOPRIL 450 255 4 3
OXYCODONE HCL 401 61 S2 5 58
METFORMIN HCL 399 254 6 8
LEVOTHYROXINE SODIUM 375 258 7 2
FUROSEMIDE 357 202 8 7
CARISOPRODOL 353 39 R 9 134
SIMVASTATIN 336 198 10 1
ZOLPIDEM TARTRATE 328 79 11 24
ATENOLOL 318 187 12 13
AMLODIPINE BESYLATE 304 228 13 5
METOPROLOL TARTRATE 298 198 14 6
PROAIR HFA 297 93 15 83
PRAVASTATIN SODIUM 289 170 16 15
AZITHROMYCIN 256 82 17 38
HYDROCHLOROTHIAZIDE 199 154 18 9
FENTANYL 192 45 S2 19 65
LOVASTATIN 186 146 20 41
NAPROXEN 164 72 21 101
CIPROFLOXACIN HCL 160 85 22 77
CRESTOR 160 122 22 28
SPIRIVA 151 69 24 40
GABAPENTIN 144 48 25 17
ALENDRONATE SODIUM 143 136 26 26
IBUPROFEN 134 14 27 75
VENTOLIN HFA 129 55 28 70
NIASPAN 126 82 29 125
PAROXETINE HCL 125 80 30 59
WARFARIN SODIUM 124 96 31 10
CITALOPRAM HBR 124 61 31 16
DICLOFENAC SODIUM 123 68 33 127
SERTRALINE HCL 119 80 34 18
OXYCONTIN 117 43 S2 35 121
PANTOPRAZOLE SODIUM 110 63 36 22
CYCLOBENZAPRINE HCL 108 20 R 37 87
FLUTICASONE PROPIONATE 108 52 37 46
PROMETHAZINE HCL 107 17 R 39 185
LISINOPRIL-HYDROCHLOROTHIAZIDE 107 74 39 27
FLUOXETINE HCL 100 31 41 61
MECLIZINE HCL 100 57 41 139
OPANA ER 98 21 S2 43 317
TRAMADOL HCL 98 0 43 20
BYSTOLIC 96 46 45 148
CLOPIDOGREL 95 63 46 23
MELOXICAM 95 89 46 52
AMITRIPTYLINE HCL 94 20 R 48 94
CEPHALEXIN 93 70 49 120
TRAZODONE HCL 92 0 50 49
POTASSIUM CHLORIDE 88 51 51 19
FLOVENT HFA 85 47 52 199
LUNESTA 85 33 52 438
GLIMEPIRIDE 84 54 54 37
DIOVAN 83 58 55 31
NEXIUM 83 58 55 36
RANITIDINE HCL 83 0 55 32
GLIPIZIDE 80 27 58 57
ATORVASTATIN CALCIUM 79 70 59 11
BENICAR 79 59 59 107
ADVAIR DISKUS 78 27 61 35
ESCITALOPRAM OXALATE 75 52 62 68
FAMOTIDINE 72 39 63 60
ALLOPURINOL 67 57 64 33
AMOXICILLIN 67 16 64 108
METOPROLOL SUCCINATE 66 53 66 14
OXYCODONE HCL-ACETAMINOPHEN 65 25 S2 67 122
VENLAFAXINE HCL ER 64 17 68 84
METHYLPREDNISOLONE 63 25 69 133
PREDNISONE 62 43 70 42
PLAVIX 58 41 71 39
AMLODIPINE BESYLATE-BENAZEPRIL 58 44 71 56
SPIRONOLACTONE 58 45 71 80
MORPHINE SULFATE ER 57 0 S2 74 104
CLONIDINE HCL 55 0 75 79
VESICARE 55 21 75 157
TRILIPIX 54 54 77 195
CYMBALTA 54 24 77 67
DILTIAZEM ER 54 46 77 247
FLUCONAZOLE 51 0 80 259
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.